Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.

AIMS The aim of this study was to investigate myocardial 2D strain echocardiography and cardiac biomarkers in the assessment of cardiac function in children with acute lymphoblastic leukaemia (ALL) during and shortly after treatment with anthracyclines. METHODS AND RESULTS Cardiac function of 60 children with ALL was prospectively studied with measurements of cardiac troponin T (cTnT) and N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and conventional and myocardial 2D strain echocardiography before start (T = 0), after 3 months (T = 1), and after 1 year (T = 2), and were compared with 60 healthy age-matched controls. None of the patients showed clinical signs of cardiac failure or abnormal fractional shortening. Cardiac function decreased significantly during treatment and was significantly decreased compared with normal controls. Cardiac troponin T levels were abnormal in 11% of the patients at T = 1 and were significantly related to increased time to global peak systolic longitudinal strain at T = 2 (P = 0.003). N-terminal-pro-brain natriuretic peptide levels were abnormal in 13% of patients at T = 1 and in 20% at T = 2, absolute values increased throughout treatment in 59%. Predictors for abnormal NT-pro-BNP at T = 2 were abnormal NT-pro-BNP at T = 0 and T = 1, for abnormal myocardial 2D strain parameters at T = 2 cumulative anthracycline dose and z-score of the diastolic left ventricular internal diameter at baseline. CONCLUSION Children with newly diagnosed ALL showed decline of systolic and diastolic function during treatment with anthracyclines using cardiac biomarkers and myocardial 2D strain echocardiography. N-terminal-pro-brain natriuretic peptide levels were not related to echocardiographic strain parameters and cTnT was not a predictor for abnormal strain at T = 2.Therefore, the combination of cardiac biomarkers and myocardial 2D strain echocardiography is important in the assessment of cardiac function of children with ALL treated with anthracyclines.

[1]  E J Orav,et al.  Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.

[2]  C. D. de Korte,et al.  Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-d echocardiography in patients treated with anthracyclines. , 2009, Ultrasound in medicine & biology.

[3]  J. Cleland,et al.  Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial , 2012, European journal of heart failure.

[4]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[5]  Shinobu Nakamura,et al.  Brain Natriuretic Peptide Is a Predictor of Anthracycline-Induced Cardiotoxicity , 2001, Acta Haematologica.

[6]  S. Colan,et al.  A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children , 2007, Circulation.

[7]  R. Murphy,et al.  Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study , 2010, Heart.

[8]  T. Feuth,et al.  Abnormal NT‐pro‐BNP levels in asymptomatic long‐term survivors of childhood cancer treated with anthracyclines , 2008, Pediatric blood & cancer.

[9]  C. Wippermann,et al.  Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.

[10]  J D'hooge,et al.  The relative value of strain and strain rate for defining intrinsic myocardial function. , 2012, American journal of physiology. Heart and circulatory physiology.

[11]  J. Seward,et al.  Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. , 1998, Mayo Clinic proceedings.

[12]  K. Hallermayer,et al.  Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[13]  R. Nagai,et al.  Elevated B-type natriuretic peptide levels after anthracycline administration. , 1998, American heart journal.

[14]  J. Krischer,et al.  Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Bryant,et al.  Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. , 2007, European journal of cancer.

[16]  Randolph P. Martin,et al.  Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab , 2012, Circulation. Cardiovascular imaging.

[17]  Piet Claus,et al.  Acute cardiac functional and morphological changes after Anthracycline infusions in children. , 2007, The American journal of cardiology.

[18]  J. Horáček,et al.  The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. , 2004, Neoplasma.

[19]  J. Cohn,et al.  Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure , 2007, Circulation.

[20]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[21]  P. Harst,et al.  The fibrosis marker galectin‐3 and outcome in the general population , 2012, Journal of internal medicine.

[22]  C. D. de Korte,et al.  Reference values for myocardial two-dimensional strain echocardiography in a healthy pediatric and young adult cohort. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  G. Nesbitt,et al.  Strain and Strain Rate Imaging in Cardiomyopathy , 2009, Echocardiography.

[24]  W. Kamps,et al.  Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004 , 2010, Leukemia.

[25]  Randolph P. Martin,et al.  Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. , 2011, The American journal of cardiology.

[26]  A. Tiran,et al.  Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies , 2003, Annals of Hematology.

[27]  P. Sengupta,et al.  Two-dimensional strain--a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  A. Wolff,et al.  Troponins for predicting cardiotoxicity from cancer therapy , 2000, The Lancet.

[29]  M. Panteghini,et al.  Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. , 2008, American journal of clinical pathology.

[30]  J. Potter,et al.  Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[32]  S. Colan,et al.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[33]  M. Quiñones,et al.  Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. , 1997, Journal of the American College of Cardiology.

[34]  Mario J. Garcia,et al.  Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility , 2002, Circulation.

[35]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[36]  S. Ha,et al.  Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy , 2010, Heart.

[37]  T. Mir,et al.  N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability , 2006, Clinical chemistry and laboratory medicine.

[38]  S. Lipsitz,et al.  Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  S. Lipshultz,et al.  Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies , 2005, British journal of haematology.

[40]  A. Mavinkurve-Groothuis,et al.  THE ROLE OF BIOMARKERS IN THE EARLY DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN CHILDREN: A Review of the Literature , 2008, Pediatric hematology and oncology.

[41]  Zvi Vered,et al.  Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[42]  W. Kamps,et al.  Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. , 2000, Medical and pediatric oncology.

[43]  Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. , 2000, Journal of the American College of Cardiology.

[44]  S. Fosså,et al.  Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. , 2011, The American journal of cardiology.

[45]  Ton Feuth,et al.  Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer. , 2010, Ultrasound in medicine & biology.

[46]  E. Bonifacio,et al.  Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. , 1990, Journal of the American College of Cardiology.